PHASE 2 dose ranging trial of VGT-309 for molecular imaging of cancer during pulmonary resection. Wright GM, Egan AJM, Mack JM, Clatworthy S, et al. Eur J Cardiothorac Surg 2025 Sep 23:ezaf314. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Wright GM, Egan AJM, Mack JM, Clatworthy S, et al. PHASE 2 dose ranging trial of VGT-309 for molecular imaging of cancer during pulmonary resection. Eur J Cardiothorac Surg 2025 Sep 23:ezaf314. doi: 10.1093.
PMID: 40985702